GENTA. Jago LLC shall submit to Apothecon, concurrently with its submission to GJT, a copy of (i) all reports, statements, invoices, Product Workplans, and budgets submitted by Genta Jago LLC to GJT or to the Steering Committee relating to the Product, (ii) a copy of all reports relating to the Product submitted to GJT under section 5.4 of the GEOMATRIX Research and Development Agreement, and (iii) a copy of all submissions to, and all responses and approvals obtained from, a regulatory authority relating to the Product. Genta Jago LLC shall promptly inform Apothecon of any default by GJT under the GEOMATRIX Research and Development Agreement. Following any such default, Apothecon shall have the right, but shall not be under any obligation of any nature whatsoever, expressly or impliedly, to (i) cure any such default, and/or (ii) pay Genta Jago LLC directly thereafter for all services performed by it under the GEOMATRIX Research and Development Agreement that pertain to the Product and deduct and offset same from any monies payable thereafter by Apothecon to GJT.
Appears in 2 contracts
Sources: License Agreement (Genta Incorporated /De/), Development and Marketing Agreement (Genta Incorporated /De/)